Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gynecomastia × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 272 Carcinoma, Intraductal, Noninfiltrating 25 Breast Carcinoma In Situ 21 Neoplasm Metastasis 14 Neoplasms 12 Breast Neoplasms, Male 12 Ovarian Neoplasms 9 Inflammatory Breast Neoplasms 7 Glioblastoma 6 Prostatic Neoplasms 5 Endometrial Neoplasms 5 Central Nervous System Neoplasms 5 Gliosarcoma 4 Fallopian Tube Neoplasms 4 Breast Cancer Female 4 Brain Neoplasms 4 Recurrence 3 Obesity 3 Hot Flashes 3 Glioma 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Astrocytoma 3 Urinary Bladder Neoplasms 2 Sleep Wake Disorders 2 Sarcoma 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Multiple Endocrine Neoplasia Type 1 2 Medulloblastoma 2

Interventions

bicalutamide 1 Tamoxifen 1 Mastectomy, Segmental 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637871 2011-01-24

Casodex - Nolvadex Combination

AstraZeneca

Phase 2 Completed

Gynecomastia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡